GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Regencell Bioscience Holdings Ltd (NAS:RGC) » Definitions » Book Value per Share

Regencell Bioscience Holdings (Regencell Bioscience Holdings) Book Value per Share : $0.92 (As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Regencell Bioscience Holdings Book Value per Share?

Regencell Bioscience Holdings's book value per share for the quarter that ended in Jun. 2023 was $0.92.

During the past 12 months, Regencell Bioscience Holdings's average Book Value Per Share Growth Rate was -29.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

Regencell Bioscience Holdings's current price is $5.56. Its book value per share for the quarter that ended in Jun. 2023 was $0.92. Hence, today's PB Ratio of Regencell Bioscience Holdings is 6.02.

During the past 5 years, the highest P/B Ratio of Regencell Bioscience Holdings was 31.79. The lowest was 0.00. And the median was 0.00.


Regencell Bioscience Holdings Book Value per Share Historical Data

The historical data trend for Regencell Bioscience Holdings's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regencell Bioscience Holdings Book Value per Share Chart

Regencell Bioscience Holdings Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23
Book Value per Share
-0.15 -0.21 -0.32 1.31 0.92

Regencell Bioscience Holdings Semi-Annual Data
Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Book Value per Share Get a 7-Day Free Trial Premium Member Only -0.32 1.52 1.31 1.13 0.92

Competitive Comparison of Regencell Bioscience Holdings's Book Value per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Regencell Bioscience Holdings's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Regencell Bioscience Holdings's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Regencell Bioscience Holdings's PB Ratio distribution charts can be found below:

* The bar in red indicates where Regencell Bioscience Holdings's PB Ratio falls into.



Regencell Bioscience Holdings Book Value per Share Calculation

Regencell Bioscience Holdings's Book Value Per Share for the fiscal year that ended in Jun. 2023 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(12.03-0.00)/13.01
=0.92

Regencell Bioscience Holdings's Book Value Per Share for the quarter that ended in Jun. 2023 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(12.03-0.00)/13.01
=0.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.


Regencell Bioscience Holdings  (NAS:RGC) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


Regencell Bioscience Holdings Book Value per Share Related Terms

Thank you for viewing the detailed overview of Regencell Bioscience Holdings's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Regencell Bioscience Holdings (Regencell Bioscience Holdings) Business Description

Traded in Other Exchanges
N/A
Address
29 Leighton Road, 9/F Chinachem Leighton Plaza, Causeway Bay, Hong Kong, HKG
Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional Chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.

Regencell Bioscience Holdings (Regencell Bioscience Holdings) Headlines

From GuruFocus